American Healthcare: Truist Securities maintains Buy rating, PT raised to $46.

American Healthcare: Truist Securities maintains Buy rating, PT raised to $46.

Truist Financial Corporation (NYSE:TFC) has seen a positive response from analysts, who have maintained their Buy rating while increasing the price target for the company. The latest update comes from TD Cowen, which has set a new price objective of $46.00 for TFC shares [1].

The stock has been gaining traction among institutional investors, with Hotchkis & Wiley Capital Management LLC boosting its stake by 9.3% in the first quarter, owning approximately 4.34 million shares valued at $178.7 million. Additionally, Brighton Jones LLC increased its holdings by 148.5% in the last quarter, now owning 23,581 shares of the insurance provider's stock worth $1,023,000 [1].

Truist Financial recently announced a quarterly dividend of $0.52 per share, representing an annualized yield of 4.5% with a dividend payout ratio of approximately 56.68%. The company also reported earnings per share of $0.91 for the quarter, missing the consensus estimate of $0.93 by ($0.02) [1].

Analysts have been bullish on Truist Financial, with two equities research analysts assigning a Strong Buy rating, nine issuing a Buy rating, and six giving a Hold rating to the stock. The company has an average rating of "Moderate Buy" and an average price target of $48.47 [1].

The stock has seen a trading increase of 4.1% with a market capitalization of $59.17 billion, a PE ratio of 12.50, and a beta of 0.87. The company's 50-day moving average is $43.76, and the 200-day moving average is $41.81 [1].

References:
[1] https://www.marketbeat.com/instant-alerts/filing-hotchkis-wiley-capital-management-llc-boosts-stake-in-truist-financial-corporation-tfc-2025-08-23/